Zhihua Ran

999 total citations
27 papers, 278 citations indexed

About

Zhihua Ran is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Zhihua Ran has authored 27 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 15 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Zhihua Ran's work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (14 papers) and Eosinophilic Esophagitis (5 papers). Zhihua Ran is often cited by papers focused on Inflammatory Bowel Disease (22 papers), Microscopic Colitis (14 papers) and Eosinophilic Esophagitis (5 papers). Zhihua Ran collaborates with scholars based in China, Japan and United States. Zhihua Ran's co-authors include Jun Shen, Mingming Zhu, Di Zhao, Antao Xu, Yuan Cao, Jun Shen, Bing Xia, Siew C. Ng, Xiaobing Wang and Lu Song and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Zhihua Ran

26 papers receiving 274 citations

Peers

Countries citing papers authored by Zhihua Ran

Since Specialization

Citations

This map shows the geographic impact of Zhihua Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihua Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihua Ran more than expected).

Fields of papers citing papers by Zhihua Ran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihua Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihua Ran. The network helps show where Zhihua Ran may publish in the future.

Co-authorship network of co-authors of Zhihua Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihua Ran. A scholar is included among the top collaborators of Zhihua Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihua Ran. Zhihua Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China 2023 ·Frontiers of Medicine ·Jie Jin, Zhihua Ran, (unknown), Bernard Roubert, (unknown), Anna Mezzacasa, (unknown)	1
2	Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia 2022 ·Intestinal Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Jinlu Tong, Qing Zheng, Kaichun Wu, Jiaming Qian, Zhihua Ran	4
3	S805 Efficacy of Upadacitinib Dose Escalation in a Phase 3 Long-Term Extension Ulcerative Colitis Study 2022 ·The American Journal of Gastroenterology ·Remo Panaccione, Millie D. Long, Zhihua Ran, Raja Atreya, Hiroshi Nakase, (unknown), Xuan Yao, Dapo Ilo, Geert D’Haens	3
4	Risks of Cardiovascular Events in Patients With Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study 2021 ·Inflammatory Bowel Diseases ·Leilei Fang, Han Gao, Xiang Gao, Wei Wu, Yinglei Miao, Hongjie Zhang, Bayasi Guleng, Hu Zhang, Yufang Wang, Mingsong Li, Hong Yang, Jie Liang, Qian Cao, Jun Shen, Zhihua Ran, Kaichun Wu, Jiaming Qian, Minhu Chen, Zhanju Liu	11
5	Multi-factor mediated functional modules identify novel classification of ulcerative colitis and functional gene panel 2021 ·Scientific Reports ·(unknown), (unknown), Qi Feng, Jun Shen, Zhihua Ran	10
6	The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study 2021 ·PLoS ONE ·(unknown), Xiaoping Xu, (unknown), Xiao Liang, Zhihua Ran, Hong Lü	8
7	775a Risankizumab Induction Therapy in Patients With Moderate-to-Severe Crohn’s Disease with Intolerance or Inadequate Response to Conventional and/or Biologic Therapy: Results from the Phase 3 ADVANCE Study 2021 ·Gastroenterology ·Geert D’Haens, Jean‐Frédéric Colombel, Peter Bossuyt, Silvio Danese, Allen Lim, James O. Lindsay, Tadakazu Hisamatsu, Zhihua Ran, David T. Rubin, Ezequiel Neimark, Bidan Huang, Xiaomei Liao, Sofie Berg, W. Rachel Duan, Kori Wallace, William J. Sandborn	3
8	775b Olamkicept, an IL-6 Trans-Signaling Inhibitor, is Effective for Induction of Response and Remission in A Randomized, Placebo-Controlled Trial in Moderate to Severe Ulcerative Colitis 2021 ·Gastroenterology ·Baili Chen, Shenghong Zhang, Bangmao Wang, Hong Chen, Yan Li, Qian Cao, Jie Zhong, (unknown), Zhihua Ran, Tongyu Tang, Michelle Yang, Taylor B. Guo, Beibei Xu, Zhiyu Cai, Lijia Ma, Stefan Schreiber, Minhu Chen	10
9	Associations Between Obesity and the Effectiveness of Anti–Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis 2020 ·Annals of Pharmacotherapy ·(unknown), (unknown), Zhihua Ran	30
10	Chromoendoscopy with targeted biopsies is superior to white-light endoscopy for the long-term follow-up detection of dysplasia in ulcerative colitis patients: a multicenter randomized–controlled trial 2020 ·Gastroenterology report ·Jian Wan, Qin Zhang, Shuhui Liang, Jie Zhong, Jingnan Li, Zhihua Ran, Fachao Zhi, Xiaodi Wang, Xiaolan Zhang, Zhonghui Wen, Jianqiu Sheng, Huaxiu Shi, Qiao Mei, Kaichun Wu	16
11	Knowledge and viewpoints on biosimilar monoclonal antibodies from members of the Asian Organization of Crohn’s and Colitis: comparison with European Crohn’s and Colitis members 2018 ·Intestinal Research ·Soo‐Kyung Park, Tadakazu Hisamatsu, Zhihua Ran, Shu‐Chen Wei, Dong Il Park	1
12	The safety and efficacy of infliximab in patients with active ulcerative colitis in China 2017 ·Baili Chen, Jiaming Qian, Kaichun Wu, Jianqiu Sheng, Jianming Xu, Zhihua Ran, Yaozong Yuan, Huahong Wang, Zhifen Chen, Zhaoshen Li, Chengwei Tang, Xiaohua Hou, Yanyan Hou, Minhu Chen	2
13	Status of serum vitamin B₁₂and folate in patients with inflammatory bowel disease in China 2017 ·Intestinal Research ·(unknown), (unknown), Mingming Zhu, Zhihua Ran	17
14	Vancomycin pre-treatment impairs tissue healing in experimental colitis: Importance of innate lymphoid cells 2016 ·Biochemical and Biophysical Research Communications ·Di Zhao, (unknown), Qing Zheng, Shuang Jin, (unknown), Jun Shen, Zhihua Ran	10
15	WNT5A transforms intestinal CD8αα+ IELs into an unconventional phenotype with pro-inflammatory features 2015 ·BMC Gastroenterology ·Di Zhao, Antao Xu, (unknown), (unknown), Mingming Zhu, Jun Shen, Qing Zheng, Zhihua Ran	4
16	Effects of Immunosuppressants on Immune Response to Vaccine in Inflammatory Bowel Disease 2015 ·Chinese Medical Journal ·Yuan Cao, Di Zhao, Antao Xu, Jun Shen, Zhihua Ran	13
17	The Impact of Clostridum Difficile on Surgical Rate Among Ulcerative Colitis Patients: A Systemic Review and Meta-analysis 2015 ·Saudi Journal of Gastroenterology ·(unknown), Jun Shen, (unknown), Zhihua Ran	13
18	Exome Sequencing Identifies DLG1 as a Novel Gene for Potential Susceptibility to Crohn's Disease in a Chinese Family Study 2014 ·PLoS ONE ·(unknown), Feng Zhou, Jinsheng Tao, Lu Song, Siew C. Ng, Xiaobing Wang, Liping Chen, Fengming Yi, Zhihua Ran, (unknown), Bing Xia	17
19	Different therapeutic approaches on quality of life in patients with inflammatory bowel disease 2014 ·BMC Gastroenterology ·Junjie Xu, (unknown), Feng Xu, Minyue Tang, Jun Shen, Zhihua Ran	12
20	Intestinal protein expression profile identifies inflammatory bowel disease and predicts relapse. 2013 ·PubMed ·Jun Shen, (unknown), Zhihua Ran, (unknown), Jiangtao Xu, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact